and outcomes research. The software performs full-text and metadata extraction from clinical papers while maintaining human-in-the-loop review for clinical validation. Evisyna structures its workflows to align with regulatory expectations such as FDA 21 CFR Part 11, HIPAA, and SOC 2 guidelines. The platform is intended to help research teams manage literature synthesis and prepare documentation for regulatory drug approval processes. Evisyna offers its capabilities as a software-as-a-service solution tailored to clinical and pharmaceutical research use cases.